Click for best price
Broluzumab Biosimilars Market Size, Share 2023
Brolucizumab is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). The most common side effects are reduced visual acuity, cataract (clouding of the lens in the eye), conjunctival haemorrhage (bleeding at the front of the eye) and vitreous floaters (spots in the vision). The most serious side effects are blindness, endophthalmitis (an infection inside the eye), retinal artery occlusion (blockage of the artery in the retina) and retinal detachment (separation of the retina from the back of the eye). Brolucizumab was designed to attach to and block a substance called vascular endothelial growth factor A (VEGF-A). VEGF-A is a protein that makes blood vessels grow and leak fluid and blood, damaging the macula. By blocking VEGF-A, brolucizumab reduces the growth of the blood vessels and controls the leakage and swelling.
This report aims to provide a comprehensive presentation of the global market for Broluzumab Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Broluzumab Biosimilars. This report contains market size and forecasts of Broluzumab Biosimilars in global, including the following market information:
Global Broluzumab Biosimilars Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Broluzumab Biosimilars Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Broluzumab Biosimilars companies in 2022 (%)
The global Broluzumab Biosimilars market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Beovu Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Broluzumab Biosimilars include Novartis, Genentech, Roche, Pfizer, Sartorius, Eli Lilly, Bayer, Amgen and PlantForm, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Broluzumab Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Broluzumab Biosimilars Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Broluzumab Biosimilars Market Segment Percentages, by Type, 2022 (%)
Beovu
Vsiqq
Others
Global Broluzumab Biosimilars Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Broluzumab Biosimilars Market Segment Percentages, by Application, 2022 (%)
ARMD
Kaposi Sarcoma
Glioblastoma
Global Broluzumab Biosimilars Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Broluzumab Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Broluzumab Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Broluzumab Biosimilars revenues share in global market, 2022 (%)
Key companies Broluzumab Biosimilars sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Broluzumab Biosimilars sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Genentech
Roche
Pfizer
Sartorius
Eli Lilly
Bayer
Amgen
PlantForm
PharmaPraxis
Samsung Bioepis
Centus
Cadila Pharmaceuticals
Dr Reddy's
Aurobindo Pharma
Biocad
MAbxience
Hetero
Biocon
Kirin Biologics
Mylan
BeiGene
Innovent
Qilu Pharmaceutical
Hengrui Pharmaceuticals
Hisun Pharmaceutical
TOT BIOPHARM
Luye Pharmaceutical
Henlius
Outline of Major Chapters:
Chapter 1: Introduces the definition of Broluzumab Biosimilars, market overview.
Chapter 2: Global Broluzumab Biosimilars market size in revenue and volume.
Chapter 3: Detailed analysis of Broluzumab Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Broluzumab Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Broluzumab Biosimilars capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Broluzumab Biosimilars Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
128 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Broluzumab Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Broluzumab Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Broluzumab Biosimilars Overall Market Size
2.1 Global Broluzumab Biosimilars Market Size: 2022 VS 2032
2.2 Global Broluzumab Biosimilars Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Broluzumab Biosimilars Sales: 2018-2032
3 Company Landscape
3.1 Top Broluzumab Biosimilars Players in Global Market
3.2 Top Global Broluzumab Biosimilars Companies Ranked by Revenue
3.3 Global Broluzumab Biosimilars Revenue by Companies
3.4 Global Broluzumab Biosimilars Sales by Companies
3.5 Global Broluzumab Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Broluzumab Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Broluzumab Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Broluzumab Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Broluzumab Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Broluzumab Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Broluzumab Biosimilars Market Size Markets, 2022 & 2032
4.1.2 Beovu
4.1.3 Vsiqq
4.1.4 Others
4.2 By Type - Global Broluzumab Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Broluzumab Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Broluzumab Biosimilars Revenue, 2024-2032
4.2.3 By Type - Global Broluzumab Biosimilars Revenue Market Share, 2018-2032
4.3 By Type - Global Broluzumab Biosimilars Sales & Forecasts
4.3.1 By Type - Global Broluzumab Biosimilars Sales, 2018-2023
4.3.2 By Type - Global Broluzumab Biosimilars Sales, 2024-2032
4.3.3 By Type - Global Broluzumab Biosimilars Sales Market Share, 2018-2032
4.4 By Type - Global Broluzumab Biosimilars Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Broluzumab Biosimilars Market Size, 2022 & 2032
5.1.2 ARMD
5.1.3 Kaposi Sarcoma
5.1.4 Glioblastoma
5.2 By Application - Global Broluzumab Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Broluzumab Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Broluzumab Biosimilars Revenue, 2024-2032
5.2.3 By Application - Global Broluzumab Biosimilars Revenue Market Share, 2018-2032
5.3 By Application - Global Broluzumab Biosimilars Sales & Forecasts
5.3.1 By Application - Global Broluzumab Biosimilars Sales, 2018-2023
5.3.2 By Application - Global Broluzumab Biosimilars Sales, 2024-2032
5.3.3 By Application - Global Broluzumab Biosimilars Sales Market Share, 2018-2032
5.4 By Application - Global Broluzumab Biosimilars Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Broluzumab Biosimilars Market Size, 2022 & 2032
6.2 By Region - Global Broluzumab Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Broluzumab Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Broluzumab Biosimilars Revenue, 2024-2032
6.2.3 By Region - Global Broluzumab Biosimilars Revenue Market Share, 2018-2032
6.3 By Region - Global Broluzumab Biosimilars Sales & Forecasts
6.3.1 By Region - Global Broluzumab Biosimilars Sales, 2018-2023
6.3.2 By Region - Global Broluzumab Biosimilars Sales, 2024-2032
6.3.3 By Region - Global Broluzumab Biosimilars Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Broluzumab Biosimilars Revenue, 2018-2032
6.4.2 By Country - North America Broluzumab Biosimilars Sales, 2018-2032
6.4.3 US Broluzumab Biosimilars Market Size, 2018-2032
6.4.4 Canada Broluzumab Biosimilars Market Size, 2018-2032
6.4.5 Mexico Broluzumab Biosimilars Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Broluzumab Biosimilars Revenue, 2018-2032
6.5.2 By Country - Europe Broluzumab Biosimilars Sales, 2018-2032
6.5.3 Germany Broluzumab Biosimilars Market Size, 2018-2032
6.5.4 France Broluzumab Biosimilars Market Size, 2018-2032
6.5.5 U.K. Broluzumab Biosimilars Market Size, 2018-2032
6.5.6 Italy Broluzumab Biosimilars Market Size, 2018-2032
6.5.7 Russia Broluzumab Biosimilars Market Size, 2018-2032
6.5.8 Nordic Countries Broluzumab Biosimilars Market Size, 2018-2032
6.5.9 Benelux Broluzumab Biosimilars Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Broluzumab Biosimilars Revenue, 2018-2032
6.6.2 By Region - Asia Broluzumab Biosimilars Sales, 2018-2032
6.6.3 China Broluzumab Biosimilars Market Size, 2018-2032
6.6.4 Japan Broluzumab Biosimilars Market Size, 2018-2032
6.6.5 South Korea Broluzumab Biosimilars Market Size, 2018-2032
6.6.6 Southeast Asia Broluzumab Biosimilars Market Size, 2018-2032
6.6.7 India Broluzumab Biosimilars Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Broluzumab Biosimilars Revenue, 2018-2032
6.7.2 By Country - South America Broluzumab Biosimilars Sales, 2018-2032
6.7.3 Brazil Broluzumab Biosimilars Market Size, 2018-2032
6.7.4 Argentina Broluzumab Biosimilars Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Broluzumab Biosimilars Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Broluzumab Biosimilars Sales, 2018-2032
6.8.3 Turkey Broluzumab Biosimilars Market Size, 2018-2032
6.8.4 Israel Broluzumab Biosimilars Market Size, 2018-2032
6.8.5 Saudi Arabia Broluzumab Biosimilars Market Size, 2018-2032
6.8.6 UAE Broluzumab Biosimilars Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Broluzumab Biosimilars Major Product Offerings
7.1.4 Novartis Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Genentech
7.2.1 Genentech Company Summary
7.2.2 Genentech Business Overview
7.2.3 Genentech Broluzumab Biosimilars Major Product Offerings
7.2.4 Genentech Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Genentech Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Broluzumab Biosimilars Major Product Offerings
7.3.4 Roche Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Broluzumab Biosimilars Major Product Offerings
7.4.4 Pfizer Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Sartorius
7.5.1 Sartorius Company Summary
7.5.2 Sartorius Business Overview
7.5.3 Sartorius Broluzumab Biosimilars Major Product Offerings
7.5.4 Sartorius Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Sartorius Key News & Latest Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Company Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Broluzumab Biosimilars Major Product Offerings
7.6.4 Eli Lilly Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Eli Lilly Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Broluzumab Biosimilars Major Product Offerings
7.7.4 Bayer Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Broluzumab Biosimilars Major Product Offerings
7.8.4 Amgen Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 PlantForm
7.9.1 PlantForm Company Summary
7.9.2 PlantForm Business Overview
7.9.3 PlantForm Broluzumab Biosimilars Major Product Offerings
7.9.4 PlantForm Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 PlantForm Key News & Latest Developments
7.10 PharmaPraxis
7.10.1 PharmaPraxis Company Summary
7.10.2 PharmaPraxis Business Overview
7.10.3 PharmaPraxis Broluzumab Biosimilars Major Product Offerings
7.10.4 PharmaPraxis Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 PharmaPraxis Key News & Latest Developments
7.11 Samsung Bioepis
7.11.1 Samsung Bioepis Company Summary
7.11.2 Samsung Bioepis Broluzumab Biosimilars Business Overview
7.11.3 Samsung Bioepis Broluzumab Biosimilars Major Product Offerings
7.11.4 Samsung Bioepis Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 Samsung Bioepis Key News & Latest Developments
7.12 Centus
7.12.1 Centus Company Summary
7.12.2 Centus Broluzumab Biosimilars Business Overview
7.12.3 Centus Broluzumab Biosimilars Major Product Offerings
7.12.4 Centus Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Centus Key News & Latest Developments
7.13 Cadila Pharmaceuticals
7.13.1 Cadila Pharmaceuticals Company Summary
7.13.2 Cadila Pharmaceuticals Broluzumab Biosimilars Business Overview
7.13.3 Cadila Pharmaceuticals Broluzumab Biosimilars Major Product Offerings
7.13.4 Cadila Pharmaceuticals Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.13.5 Cadila Pharmaceuticals Key News & Latest Developments
7.14 Dr Reddy's
7.14.1 Dr Reddy's Company Summary
7.14.2 Dr Reddy's Business Overview
7.14.3 Dr Reddy's Broluzumab Biosimilars Major Product Offerings
7.14.4 Dr Reddy's Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.14.5 Dr Reddy's Key News & Latest Developments
7.15 Aurobindo Pharma
7.15.1 Aurobindo Pharma Company Summary
7.15.2 Aurobindo Pharma Business Overview
7.15.3 Aurobindo Pharma Broluzumab Biosimilars Major Product Offerings
7.15.4 Aurobindo Pharma Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.15.5 Aurobindo Pharma Key News & Latest Developments
7.16 Biocad
7.16.1 Biocad Company Summary
7.16.2 Biocad Business Overview
7.16.3 Biocad Broluzumab Biosimilars Major Product Offerings
7.16.4 Biocad Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.16.5 Biocad Key News & Latest Developments
7.17 MAbxience
7.17.1 MAbxience Company Summary
7.17.2 MAbxience Business Overview
7.17.3 MAbxience Broluzumab Biosimilars Major Product Offerings
7.17.4 MAbxience Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.17.5 MAbxience Key News & Latest Developments
7.18 Hetero
7.18.1 Hetero Company Summary
7.18.2 Hetero Business Overview
7.18.3 Hetero Broluzumab Biosimilars Major Product Offerings
7.18.4 Hetero Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.18.5 Hetero Key News & Latest Developments
7.19 Biocon
7.19.1 Biocon Company Summary
7.19.2 Biocon Business Overview
7.19.3 Biocon Broluzumab Biosimilars Major Product Offerings
7.19.4 Biocon Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.19.5 Biocon Key News & Latest Developments
7.20 Kirin Biologics
7.20.1 Kirin Biologics Company Summary
7.20.2 Kirin Biologics Business Overview
7.20.3 Kirin Biologics Broluzumab Biosimilars Major Product Offerings
7.20.4 Kirin Biologics Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.20.5 Kirin Biologics Key News & Latest Developments
7.21 Mylan
7.21.1 Mylan Company Summary
7.21.2 Mylan Business Overview
7.21.3 Mylan Broluzumab Biosimilars Major Product Offerings
7.21.4 Mylan Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.21.5 Mylan Key News & Latest Developments
7.22 BeiGene
7.22.1 BeiGene Company Summary
7.22.2 BeiGene Business Overview
7.22.3 BeiGene Broluzumab Biosimilars Major Product Offerings
7.22.4 BeiGene Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.22.5 BeiGene Key News & Latest Developments
7.23 Innovent
7.23.1 Innovent Company Summary
7.23.2 Innovent Business Overview
7.23.3 Innovent Broluzumab Biosimilars Major Product Offerings
7.23.4 Innovent Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.23.5 Innovent Key News & Latest Developments
7.24 Qilu Pharmaceutical
7.24.1 Qilu Pharmaceutical Company Summary
7.24.2 Qilu Pharmaceutical Business Overview
7.24.3 Qilu Pharmaceutical Broluzumab Biosimilars Major Product Offerings
7.24.4 Qilu Pharmaceutical Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.24.5 Qilu Pharmaceutical Key News & Latest Developments
7.25 Hengrui Pharmaceuticals
7.25.1 Hengrui Pharmaceuticals Company Summary
7.25.2 Hengrui Pharmaceuticals Business Overview
7.25.3 Hengrui Pharmaceuticals Broluzumab Biosimilars Major Product Offerings
7.25.4 Hengrui Pharmaceuticals Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.25.5 Hengrui Pharmaceuticals Key News & Latest Developments
7.26 Hisun Pharmaceutical
7.26.1 Hisun Pharmaceutical Company Summary
7.26.2 Hisun Pharmaceutical Business Overview
7.26.3 Hisun Pharmaceutical Broluzumab Biosimilars Major Product Offerings
7.26.4 Hisun Pharmaceutical Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.26.5 Hisun Pharmaceutical Key News & Latest Developments
7.27 TOT BIOPHARM
7.27.1 TOT BIOPHARM Company Summary
7.27.2 TOT BIOPHARM Business Overview
7.27.3 TOT BIOPHARM Broluzumab Biosimilars Major Product Offerings
7.27.4 TOT BIOPHARM Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.27.5 TOT BIOPHARM Key News & Latest Developments
7.28 Luye Pharmaceutical
7.28.1 Luye Pharmaceutical Company Summary
7.28.2 Luye Pharmaceutical Business Overview
7.28.3 Luye Pharmaceutical Broluzumab Biosimilars Major Product Offerings
7.28.4 Luye Pharmaceutical Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.28.5 Luye Pharmaceutical Key News & Latest Developments
7.29 Henlius
7.29.1 Henlius Company Summary
7.29.2 Henlius Business Overview
7.29.3 Henlius Broluzumab Biosimilars Major Product Offerings
7.29.4 Henlius Broluzumab Biosimilars Sales and Revenue in Global (2018-2023)
7.29.5 Henlius Key News & Latest Developments
8 Global Broluzumab Biosimilars Production Capacity, Analysis
8.1 Global Broluzumab Biosimilars Production Capacity, 2018-2032
8.2 Broluzumab Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Broluzumab Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Broluzumab Biosimilars Supply Chain Analysis
10.1 Broluzumab Biosimilars Industry Value Chain
10.2 Broluzumab Biosimilars Upstream Market
10.3 Broluzumab Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Broluzumab Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Broluzumab Biosimilars in Global Market
Table 2. Top Broluzumab Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Broluzumab Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Broluzumab Biosimilars Revenue Share by Companies, 2018-2023
Table 5. Global Broluzumab Biosimilars Sales by Companies, (K Units), 2018-2023
Table 6. Global Broluzumab Biosimilars Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Broluzumab Biosimilars Price (2018-2023) & (K USD/Unit)
Table 8. Global Manufacturers Broluzumab Biosimilars Product Type
Table 9. List of Global Tier 1 Broluzumab Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Broluzumab Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Broluzumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Broluzumab Biosimilars Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Broluzumab Biosimilars Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Broluzumab Biosimilars Sales (K Units), 2018-2023
Table 15. By Type - Global Broluzumab Biosimilars Sales (K Units), 2024-2032
Table 16. By Application ? Global Broluzumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Broluzumab Biosimilars Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Broluzumab Biosimilars Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Broluzumab Biosimilars Sales (K Units), 2018-2023
Table 20. By Application - Global Broluzumab Biosimilars Sales (K Units), 2024-2032
Table 21. By Region ? Global Broluzumab Biosimilars Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Broluzumab Biosimilars Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Broluzumab Biosimilars Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Broluzumab Biosimilars Sales (K Units), 2018-2023
Table 25. By Region - Global Broluzumab Biosimilars Sales (K Units), 2024-2032
Table 26. By Country - North America Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Broluzumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Broluzumab Biosimilars Sales, (K Units), 2018-2023
Table 29. By Country - North America Broluzumab Biosimilars Sales, (K Units), 2024-2032
Table 30. By Country - Europe Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Broluzumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Broluzumab Biosimilars Sales, (K Units), 2018-2023
Table 33. By Country - Europe Broluzumab Biosimilars Sales, (K Units), 2024-2032
Table 34. By Region - Asia Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Broluzumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Broluzumab Biosimilars Sales, (K Units), 2018-2023
Table 37. By Region - Asia Broluzumab Biosimilars Sales, (K Units), 2024-2032
Table 38. By Country - South America Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Broluzumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Broluzumab Biosimilars Sales, (K Units), 2018-2023
Table 41. By Country - South America Broluzumab Biosimilars Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Broluzumab Biosimilars Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Broluzumab Biosimilars Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Broluzumab Biosimilars Sales, (K Units), 2024-2032
Table 46. Novartis Company Summary
Table 47. Novartis Broluzumab Biosimilars Product Offerings
Table 48. Novartis Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Genentech Company Summary
Table 51. Genentech Broluzumab Biosimilars Product Offerings
Table 52. Genentech Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 53. Genentech Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Broluzumab Biosimilars Product Offerings
Table 56. Roche Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Broluzumab Biosimilars Product Offerings
Table 60. Pfizer Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Sartorius Company Summary
Table 63. Sartorius Broluzumab Biosimilars Product Offerings
Table 64. Sartorius Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 65. Sartorius Key News & Latest Developments
Table 66. Eli Lilly Company Summary
Table 67. Eli Lilly Broluzumab Biosimilars Product Offerings
Table 68. Eli Lilly Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 69. Eli Lilly Key News & Latest Developments
Table 70. Bayer Company Summary
Table 71. Bayer Broluzumab Biosimilars Product Offerings
Table 72. Bayer Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 73. Bayer Key News & Latest Developments
Table 74. Amgen Company Summary
Table 75. Amgen Broluzumab Biosimilars Product Offerings
Table 76. Amgen Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 77. Amgen Key News & Latest Developments
Table 78. PlantForm Company Summary
Table 79. PlantForm Broluzumab Biosimilars Product Offerings
Table 80. PlantForm Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 81. PlantForm Key News & Latest Developments
Table 82. PharmaPraxis Company Summary
Table 83. PharmaPraxis Broluzumab Biosimilars Product Offerings
Table 84. PharmaPraxis Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 85. PharmaPraxis Key News & Latest Developments
Table 86. Samsung Bioepis Company Summary
Table 87. Samsung Bioepis Broluzumab Biosimilars Product Offerings
Table 88. Samsung Bioepis Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 89. Samsung Bioepis Key News & Latest Developments
Table 90. Centus Company Summary
Table 91. Centus Broluzumab Biosimilars Product Offerings
Table 92. Centus Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 93. Centus Key News & Latest Developments
Table 94. Cadila Pharmaceuticals Company Summary
Table 95. Cadila Pharmaceuticals Broluzumab Biosimilars Product Offerings
Table 96. Cadila Pharmaceuticals Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 97. Cadila Pharmaceuticals Key News & Latest Developments
Table 98. Dr Reddy's Company Summary
Table 99. Dr Reddy's Broluzumab Biosimilars Product Offerings
Table 100. Dr Reddy's Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 101. Dr Reddy's Key News & Latest Developments
Table 102. Aurobindo Pharma Company Summary
Table 103. Aurobindo Pharma Broluzumab Biosimilars Product Offerings
Table 104. Aurobindo Pharma Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 105. Aurobindo Pharma Key News & Latest Developments
Table 106. Biocad Company Summary
Table 107. Biocad Broluzumab Biosimilars Product Offerings
Table 108. Biocad Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 109. Biocad Key News & Latest Developments
Table 110. MAbxience Company Summary
Table 111. MAbxience Broluzumab Biosimilars Product Offerings
Table 112. MAbxience Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 113. MAbxience Key News & Latest Developments
Table 114. Hetero Company Summary
Table 115. Hetero Broluzumab Biosimilars Product Offerings
Table 116. Hetero Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 117. Hetero Key News & Latest Developments
Table 118. Biocon Company Summary
Table 119. Biocon Broluzumab Biosimilars Product Offerings
Table 120. Biocon Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 121. Biocon Key News & Latest Developments
Table 122. Kirin Biologics Company Summary
Table 123. Kirin Biologics Broluzumab Biosimilars Product Offerings
Table 124. Kirin Biologics Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 125. Kirin Biologics Key News & Latest Developments
Table 126. Mylan Company Summary
Table 127. Mylan Broluzumab Biosimilars Product Offerings
Table 128. Mylan Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 129. Mylan Key News & Latest Developments
Table 130. BeiGene Company Summary
Table 131. BeiGene Broluzumab Biosimilars Product Offerings
Table 132. BeiGene Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 133. BeiGene Key News & Latest Developments
Table 134. Innovent Company Summary
Table 135. Innovent Broluzumab Biosimilars Product Offerings
Table 136. Innovent Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 137. Innovent Key News & Latest Developments
Table 138. Qilu Pharmaceutical Company Summary
Table 139. Qilu Pharmaceutical Broluzumab Biosimilars Product Offerings
Table 140. Qilu Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 141. Qilu Pharmaceutical Key News & Latest Developments
Table 142. Hengrui Pharmaceuticals Company Summary
Table 143. Hengrui Pharmaceuticals Broluzumab Biosimilars Product Offerings
Table 144. Hengrui Pharmaceuticals Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 145. Hengrui Pharmaceuticals Key News & Latest Developments
Table 146. Hisun Pharmaceutical Company Summary
Table 147. Hisun Pharmaceutical Broluzumab Biosimilars Product Offerings
Table 148. Hisun Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 149. Hisun Pharmaceutical Key News & Latest Developments
Table 150. TOT BIOPHARM Company Summary
Table 151. TOT BIOPHARM Broluzumab Biosimilars Product Offerings
Table 152. TOT BIOPHARM Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 153. TOT BIOPHARM Key News & Latest Developments
Table 154. Luye Pharmaceutical Company Summary
Table 155. Luye Pharmaceutical Broluzumab Biosimilars Product Offerings
Table 156. Luye Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 157. Luye Pharmaceutical Key News & Latest Developments
Table 158. Henlius Company Summary
Table 159. Henlius Broluzumab Biosimilars Product Offerings
Table 160. Henlius Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2018-2023)
Table 161. Henlius Key News & Latest Developments
Table 162. Broluzumab Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 163. Global Broluzumab Biosimilars Capacity Market Share of Key Manufacturers, 2021-2023
Table 164. Global Broluzumab Biosimilars Production by Region, 2018-2023 (K Units)
Table 165. Global Broluzumab Biosimilars Production by Region, 2024-2032 (K Units)
Table 166. Broluzumab Biosimilars Market Opportunities & Trends in Global Market
Table 167. Broluzumab Biosimilars Market Drivers in Global Market
Table 168. Broluzumab Biosimilars Market Restraints in Global Market
Table 169. Broluzumab Biosimilars Raw Materials
Table 170. Broluzumab Biosimilars Raw Materials Suppliers in Global Market
Table 171. Typical Broluzumab Biosimilars Downstream
Table 172. Broluzumab Biosimilars Downstream Clients in Global Market
Table 173. Broluzumab Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Broluzumab Biosimilars Segment by Type in 2022
Figure 2. Broluzumab Biosimilars Segment by Application in 2022
Figure 3. Global Broluzumab Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Broluzumab Biosimilars Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Broluzumab Biosimilars Revenue, 2018-2032 (US$, Mn)
Figure 7. Broluzumab Biosimilars Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Broluzumab Biosimilars Revenue in 2022
Figure 9. By Type - Global Broluzumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Broluzumab Biosimilars Revenue Market Share, 2018-2032
Figure 11. By Type - Global Broluzumab Biosimilars Sales Market Share, 2018-2032
Figure 12. By Type - Global Broluzumab Biosimilars Price (K USD/Unit), 2018-2032
Figure 13. By Application - Global Broluzumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Broluzumab Biosimilars Revenue Market Share, 2018-2032
Figure 15. By Application - Global Broluzumab Biosimilars Sales Market Share, 2018-2032
Figure 16. By Application - Global Broluzumab Biosimilars Price (K USD/Unit), 2018-2032
Figure 17. By Region - Global Broluzumab Biosimilars Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Broluzumab Biosimilars Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Broluzumab Biosimilars Revenue Market Share, 2018-2032
Figure 20. By Region - Global Broluzumab Biosimilars Sales Market Share, 2018-2032
Figure 21. By Country - North America Broluzumab Biosimilars Revenue Market Share, 2018-2032
Figure 22. By Country - North America Broluzumab Biosimilars Sales Market Share, 2018-2032
Figure 23. US Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Broluzumab Biosimilars Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Broluzumab Biosimilars Sales Market Share, 2018-2032
Figure 28. Germany Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 29. France Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Broluzumab Biosimilars Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Broluzumab Biosimilars Sales Market Share, 2018-2032
Figure 37. China Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 41. India Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Broluzumab Biosimilars Revenue Market Share, 2018-2032
Figure 43. By Country - South America Broluzumab Biosimilars Sales Market Share, 2018-2032
Figure 44. Brazil Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Broluzumab Biosimilars Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Broluzumab Biosimilars Sales Market Share, 2018-2032
Figure 48. Turkey Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Broluzumab Biosimilars Revenue, (US$, Mn), 2018-2032
Figure 52. Global Broluzumab Biosimilars Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Broluzumab Biosimilars by Region, 2022 VS 2032
Figure 54. Broluzumab Biosimilars Industry Value Chain
Figure 55. Marketing Channels
